Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...

BOSTON, MA, USA I1, 2025 I Antennova, a clinical-stage biotech company focused on oncology today announced the presentation of latest data from ...

The FDA says about 2,756 jars of First Aid Beauty Ultra Repair Cream Coconut Vanilla are being recalled due to a deviation from Current Good Manufacturing Practice regulations, which regulates quality ...

Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out ...

Medexus will target a commercial launch in 1H CY2025; potential for annual product-level revenue to exceed US$100 million ...

The Food and Drug Administration released on Tuesday its long-awaited proposal to require food manufacturers to put some ...

Study to be conducted under $3.6 million NIH grant DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), ...

Target (TGT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Absci Corporation ... optimize target selection and validate therapeutic hypotheses using extensive biomedical datasets and patient-derived organoids. Absci’s generative AI Drug Creation ...

One of the biggest analyst calls for Tuesday, January 7 th, was for Atlassian Corporation (NASDAQ:TEAM). Truist upgraded the stock to “Buy” from Hold, boosting the price target to $300 from $250.

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent alert to healthcare providers and the general public about a suspected counterfeit cancer drug ...